NLRP3 inflammasome inhibitor MCC950 attenuates primary dysmenorrhea in mice via the NF- κB/COX-2/PG pathway

Primary dysmenorrhea (PD) constitutes a common gynecological disease among young women. The NLRP3 inflammasome may be activated and expressed in PD, but the mechanistic link between NLRP3 inflammasome activati...

Source: Journal of Inflammation - June 24, 2020 Category: Allergy & Immunology Authors: Biao Tang, Dan Liu, Lingyu Chen and Yu Liu Tags: Research Source Type: research